The forecasted share of global top-cited publications in Pulmonary and Respiratory Medicine in the US shows a steady, slight decline from 2024 through 2028. In 2023, the share stood at 13.35%, indicating minimal year-on-year decreases. This consistent downward trend reflects a compound annual growth rate (CAGR) of -0.15% over the next five years, suggesting a modest, yet persistent drop in relative impact or global citation influence.

Future trends to watch for:

Potential shifts in research funding and priorities that could affect publication impact.
The emergence of new research centers of excellence or collaborations that may boost citation shares.
Changes in the field's dynamics and publication practices, possibly influenced by technological advances or policy changes.